Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleBrief Communications

Pharmacokinetic Properties of Peptidic Radiopharmaceuticals: Reduced Uptake of (EH)3-Conjugates in Important Organs

Matthias Eder, Thomas Löhr, Ulrike Bauder-Wüst, Markus Reber, Walter Mier, Martin Schäfer, Uwe Haberkorn and Michael Eisenhut
Journal of Nuclear Medicine August 2013, 54 (8) 1327-1330; DOI: https://doi.org/10.2967/jnumed.112.114512
Matthias Eder
1Radiopharmaceutical Chemistry, German Cancer Research Center, Heidelberg, Germany; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas Löhr
1Radiopharmaceutical Chemistry, German Cancer Research Center, Heidelberg, Germany; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ulrike Bauder-Wüst
1Radiopharmaceutical Chemistry, German Cancer Research Center, Heidelberg, Germany; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Markus Reber
1Radiopharmaceutical Chemistry, German Cancer Research Center, Heidelberg, Germany; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Walter Mier
2Department of Nuclear Medicine, University of Heidelberg, Heidelberg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Martin Schäfer
1Radiopharmaceutical Chemistry, German Cancer Research Center, Heidelberg, Germany; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Uwe Haberkorn
2Department of Nuclear Medicine, University of Heidelberg, Heidelberg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Eisenhut
1Radiopharmaceutical Chemistry, German Cancer Research Center, Heidelberg, Germany; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 54 no. 8 1327-1330
DOI 
https://doi.org/10.2967/jnumed.112.114512
PubMed 
23804326

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Received for publication September 21, 2012
  • Accepted for publication February 28, 2013
  • Published online August 1, 2013.

Article Versions

  • previous version (June 26, 2013 - 05:34).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2013 by the Society of Nuclear Medicine and Molecular Imaging, Inc.

Author Information

  1. Matthias Eder1,
  2. Thomas Löhr1,
  3. Ulrike Bauder-Wüst1,
  4. Markus Reber1,
  5. Walter Mier2,
  6. Martin Schäfer1,
  7. Uwe Haberkorn2 and
  8. Michael Eisenhut1
  1. 1Radiopharmaceutical Chemistry, German Cancer Research Center, Heidelberg, Germany; and
  2. 2Department of Nuclear Medicine, University of Heidelberg, Heidelberg, Germany
  1. For correspondence or reprints contact: Matthias Eder, Radiopharmaceutical Chemistry, German Cancer Research Center, Im Neuenheimer Feld 280, 69120 Heidelberg, Germany. E-mail: m.eder{at}dkfz.de
View Full Text

Statistics from Altmetric.com

Cited By...

  • 23 Citations
  • 23 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • Radioactive Main Group and Rare Earth Metals for Imaging and Therapy
    Thomas I. Kostelnik, Chris Orvig
    Chemical Reviews 2019 119 2
  • Pilot study: use of gallium-68 PSMA PET for detection of metastatic lesions in patients with renal tumour
    Handoo Rhee, John Blazak, Chui Ming Tham, Keng Lim Ng, Benjamin Shepherd, Malcolm Lawson, John Preston, Ian Vela, Paul Thomas, Simon Wood
    EJNMMI Research 2016 6 1
  • Prostate Specific Membrane Antigen Positron Emission Tomography May Improve the Diagnostic Accuracy of Multiparametric Magnetic Resonance Imaging in Localized Prostate Cancer
    H. Rhee, P. Thomas, B. Shepherd, S. Gustafson, I. Vela, P.J. Russell, C. Nelson, E. Chung, G. Wood, G. Malone, S. Wood, P. Heathcote
    Journal of Urology 2016 196 4
  • Radiohybrid Ligands: A Novel Tracer Concept Exemplified by 18F- or 68Ga-Labeled rhPSMA Inhibitors
    Alexander Wurzer, Daniel Di Carlo, Alexander Schmidt, Roswitha Beck, Matthias Eiber, Markus Schwaiger, Hans-Jürgen Wester
    Journal of Nuclear Medicine 2020 61 5
  • Improved specificity with 68Ga PSMA PET/CT to detect clinically significant lesions “invisible” on multiparametric MRI of the prostate: a single institution comparative analysis with radical prostatectomy histology
    Peter Donato, Matthew J. Roberts, Andrew Morton, Samuel Kyle, Geoff Coughlin, Rachel Esler, Nigel Dunglison, Robert A. Gardiner, John Yaxley
    European Journal of Nuclear Medicine and Molecular Imaging 2019 46 1
  • Novel Bispecific PSMA/GRPr Targeting Radioligands with Optimized Pharmacokinetics for Improved PET Imaging of Prostate Cancer
    C. Liolios, M. Schäfer, U. Haberkorn, M. Eder, K. Kopka
    Bioconjugate Chemistry 2016 27 3
  • Improving the Imaging Contrast of 68Ga-PSMA-11 by Targeted Linker Design: Charged Spacer Moieties Enhance the Pharmacokinetic Properties
    Ann-Christin Baranski, Martin Schäfer, Ulrike Bauder-Wüst, Anja Wacker, Jana Schmidt, Christos Liolios, Walter Mier, Uwe Haberkorn, Michael Eisenhut, Klaus Kopka, Matthias Eder
    Bioconjugate Chemistry 2017 28 9
  • Influence of Histidine-Containing Tags on the Biodistribution of ADAPT Scaffold Proteins
    Sarah Lindbo, Javad Garousi, Mikael Åstrand, Hadis Honarvar, Anna Orlova, Sophia Hober, Vladimir Tolmachev
    Bioconjugate Chemistry 2016 27 3
  • A Metal-Free DOTA-Conjugated 18F-Labeled Radiotracer: [18F]DOTA-AMBF3-LLP2A for Imaging VLA-4 Over-Expression in Murine Melanoma with Improved Tumor Uptake and Greatly Enhanced Renal Clearance
    Áron Roxin, Chengcheng Zhang, Sungjoon Huh, Mathieu Lepage, Zhengxing Zhang, Kuo-Shyan Lin, François Bénard, David M. Perrin
    Bioconjugate Chemistry 2019 30 4
  • Current State of Radiolabeled Heterobivalent Peptidic Ligands in Tumor Imaging and Therapy
    Benedikt Judmann, Diana Braun, Björn Wängler, Ralf Schirrmacher, Gert Fricker, Carmen Wängler
    Pharmaceuticals 2020 13 8

Article usage

Article usage: June 2013 to April 2025

AbstractFullPdf
Jun 2013103017
Jul 2013229028
Aug 20135631749
Sep 20131981418
Oct 2013932327
Nov 2013942517
Dec 2013492614
Jan 2014761815
Feb 2014571616
Mar 2014583117
Apr 2014512414
May 2014381112
Jun 2014301311
Jul 2014241415
Aug 201417127
Sep 2014501311
Oct 2014381714
Nov 2014221515
Dec 20141675
Jan 2015212716
Feb 201523189
Mar 201544159
Apr 2015301415
May 2015521912
Jun 2015252611
Jul 2015171522
Aug 201529134
Sep 201527159
Oct 2015181112
Nov 20151797
Dec 2015251411
Jan 2016151021
Feb 201691414
Mar 201616622
Apr 201617911
May 20161578
Jun 2016151016
Jul 201614629
Aug 2016161218
Sep 201617724
Oct 2016241021
Nov 2016101811
Dec 2016231625
Jan 2017251517
Feb 201718917
Mar 2017191624
Apr 201730157
May 201720138
Jun 2017231512
Jul 2017171411
Aug 201727149
Sep 201722125
Oct 201729199
Nov 201730812
Dec 2017211511
Jan 201817105
Feb 2018221316
Mar 2018371916
Apr 2018211510
May 201816917
Jun 2018241414
Jul 2018131112
Aug 20181469
Sep 201816166
Oct 2018232421
Nov 201847349
Dec 2018134015
Jan 2019213519
Feb 201921217
Mar 201922219
Apr 2019202512
May 201912812
Jun 2019101210
Jul 2019181510
Aug 20191238
Sep 201910107
Oct 2019846
Nov 20199610
Dec 20197415
Jan 20206102
Feb 20203613
Mar 202091110
Apr 202081014
May 20209812
Jun 202091211
Jul 202010914
Aug 2020689
Sep 2020875
Oct 20207154
Nov 202051113
Dec 20205914
Jan 202142415
Feb 202131515
Mar 20213229
Apr 202104225
May 202182323
Jun 202122112
Jul 20214119
Aug 202161315
Sep 202110617
Oct 202141539
Nov 202141033
Dec 202141715
Jan 20226919
Feb 202231514
Mar 202261716
Apr 202251817
May 202271417
Jun 202251017
Jul 202229247
Aug 2022281513
Sep 202202210
Oct 20226138
Nov 20221158
Dec 2022696
Jan 202342312
Feb 202331210
Mar 202331914
Apr 202321818
May 2023166
Jun 202331711
Jul 20234126
Aug 2023599
Sep 20235237
Oct 202351213
Nov 2023476
Dec 20230173
Jan 20243207
Feb 20241195
Mar 202431137
Apr 202461814
May 20246228
Jun 20244238
Jul 202492212
Aug 202451915
Sep 202411315
Oct 2024112716
Nov 20243134
Dec 202452110
Jan 202543025
Feb 2025135720
Mar 202533321
Apr 2025105429
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 54 (8)
Journal of Nuclear Medicine
Vol. 54, Issue 8
August 1, 2013
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Pharmacokinetic Properties of Peptidic Radiopharmaceuticals: Reduced Uptake of (EH)3-Conjugates in Important Organs
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Pharmacokinetic Properties of Peptidic Radiopharmaceuticals: Reduced Uptake of (EH)3-Conjugates in Important Organs
Matthias Eder, Thomas Löhr, Ulrike Bauder-Wüst, Markus Reber, Walter Mier, Martin Schäfer, Uwe Haberkorn, Michael Eisenhut
Journal of Nuclear Medicine Aug 2013, 54 (8) 1327-1330; DOI: 10.2967/jnumed.112.114512

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Pharmacokinetic Properties of Peptidic Radiopharmaceuticals: Reduced Uptake of (EH)3-Conjugates in Important Organs
Matthias Eder, Thomas Löhr, Ulrike Bauder-Wüst, Markus Reber, Walter Mier, Martin Schäfer, Uwe Haberkorn, Michael Eisenhut
Journal of Nuclear Medicine Aug 2013, 54 (8) 1327-1330; DOI: 10.2967/jnumed.112.114512
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • DISCLOSURE
    • Acknowledgments
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • This Month in JNM
  • PubMed
  • Google Scholar

Cited By...

  • Rational Linker Design to Accelerate Excretion and Reduce Background Uptake of Peptidomimetic PSMA-Targeting Hybrid Molecules
  • PET Imaging Quantifying 68Ga-PSMA-11 Uptake in Metastatic Colorectal Cancer
  • Radiohybrid Ligands: A Novel Tracer Concept Exemplified by 18F- or 68Ga-Labeled rhPSMA Inhibitors
  • Google Scholar

More in this TOC Section

  • Intraarterial Administration Boosts 177Lu-HA-DOTATATE Accumulation in Salvage Meningioma Patients
  • Head-to-Head Comparison of 68Ga-NOTA (68Ga-NGUL) and 68Ga-PSMA-11 in Patients with Metastatic Prostate Cancer: A Prospective Study
  • Assessment of P-Glycoprotein Transport Activity at the Human Blood–Retina Barrier with (R)‐11C-Verapamil PET
Show more Brief Communications

Similar Articles

Keywords

  • 68Ga
  • pharmacokinetic properties
  • radiopharmaceuticals
  • Peptides
SNMMI

© 2025 SNMMI

Powered by HighWire